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Autophagosome formation is stimulated by canonical VPS34-dependent formation of phosphatidylinositol
3-phosphate [PI(3)P], which recruits effectors such as WIPI2. However, non-canonical VPS34-independent autophagy
has also been proposed. We recently described that PI(5)P regulates autophagosome biogenesis, recruits WIPI2, and
rescues autophagy in VPS34-inactivated cells. These alternative autophagy-initiating pathways reveal new druggable
targets for treating neurodegeneration and cancer.
Phosphoinositides (PIs) are formed by
phosphorylation of the inositol headgroup
of phosphatidylinositol (Fig. 1A). The
combined activities of multiple phosphoi-
nositide kinases and phosphatases enable
interconvertibility and rapid local changes
in PI concentrations. When clustered, PIs
create a cytosol-facing platform that ena-
bles the binding of machineries that regu-
late membrane deformation, and PIs can
also influence the geometry of the mem-
brane due to their inverted cone shape.
Since local PI concentrations respond to
nutrient availability and cell stress they
can integrate membrane trafficking events
within other functional modules, such as
signaling and energy control.
Autophagy is a bulk degradation pro-
cess that delivers cytoplasmic materials
(long-lived proteins and damaged organ-
elles) to lysosomes, and can be induced by
amino acid starvation, growth factor with-
drawal, and low cellular energy levels. The
first morphologically recognizable precur-
sor of this process is a flattened double-
membraned sac-like structure called a
phagophore, whose edges elongate and
fuse while engulfing a small portion of the
cytoplasm to become an autophagosome
(Fig. 1B). Autophagosomes fuse with
lysosomes to form autolysosomes, whose
contents can be degraded by the lysosomal
hydrolases. Autophagy impacts the patho-
genesis of diverse diseases, including neu-
rodegenerative conditions, cancers, and
infectious diseases.1
Autophagy has been classically consid-
ered to be dependent on phosphatidylino-
sitol 3-phosphate [PI(3)P], since genetic
studies in yeast and flies suggested that PI
(3)P production by the class III phosphati-
dylinositol 3-kinase (VPS34) is required
for autophagosome formation, for several
proteins associated with autophagosome
biogenesis (double FYVE-containing
protein 1 [DFCP1] and WD-repeat pro-
tein interacting with phosphoinositide
[WIPI1-2]),2 and for other components of
the pathway.3 However, recent studies have
also suggested the existence of VPS34-inde-
pendent autophagy.4For instance, autopha-
gosomes form in T lymphocytes and
sensory neurons from Vps34¡/¡ mice5 and
in glucose-starved or resveratrol-treated
cells incubated with the VPS34 inhibitor
wortmannin.4, 6 These phenomena may be
attributed to VPS34-independent source(s)
of PI(3)P,7 or to other phosphoinositides
with similar properties to PI(3)P in the
autophagy context.
The structure of PI(5)P is related to
that of PI(3)P by rotation of the inositol
ring that interconverts the position of the
3- and 5-phosphoryl groups, such that
their charges can occupy equivalent posi-
tions (Fig. 1A). Although PI(5)P has been
implicated in growth factor signaling
pathways, chromatin organization, bacte-
rial invasion, and cytoskeletal remodel-
ing,8 our study is the first report of PI(5)P
as an autophagy regulator.9 This is com-
patible with previous observations of simi-
lar binding of PI(3)P and PI(5)P to WIPI
proteins.10
PI(5)P biosynthesis is regulated by the
type III PtdInsP 5-kinase PIKfyve, either
by direct phosphorylation of PI or via for-
mation of PI(3,5)P2, which is then trans-
formed into PI(5)P by 3-phosphatases of
the myotubularin family (MTMRs)8
(Fig. 1A). The major route for PI(5)P
removal is attributed to type II PI5PK
kinases (phosphatidylinositol 5-phosphate
4-kinases, PI5P4K)8 (Fig. 1A). We found
that increasing cellular PI(5)P levels (by
the addition of exogenous PI(5)P or
silencing of the PI5P4-kinases) enhanced
autophagosome formation and autopha-
gosome and autolysosome numbers,
whereas depleting PI(5)P (via the PIKfyve
inhibitor YM-201636 or by silencing of
PIKfyve or MTMR3) decreased the num-
bers of autophagosome precursors and
completed autophagosomes. Interestingly,
PI(5)P (and its precursor PI(3,5)P2)
localized on nascent and completed
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autophagosomes and the kinases acting on
PI(5)P localized on autophagosomes
(Fig. 1B) under different type of starva-
tion conditions.
PI(5)P resembles PI(3)P as a regulator
of autophagosome biogenesis. Acute
depletion of PI(3)P using wortmannin
completely ablated the presence of WIPI2
and DFCP1 vesicles and inhibited
ATG5-12 conjugation and autophago-
some formation. PI(5)P regulates autoph-
agy even when VPS34 is inhibited, since
the impaired autophagosome formation
caused by wortmannin or VPS34 silencing
was rescued by elevating PI(5)P levels.
Our observations that PI(5)P binds to
WIPI2, affects PI(3)P-related phenotypes
such as ATG12-5 conjugation, and can
rescue autophagy in wortmannin-treated
HBSS-starved cells, argues that it can serve
as an “alternative” to PI(3)P. Indeed, we
found that PI(3)P and PI(5)P can mutu-
ally compete for binding to the PI(3)P
autophagy effector WIPI2 in vitro. We
propose that PI(5)P might account for the
previously mysterious phenomenon of
PI(3)P-independent, non-canonical
autophagy. Since PI(5)P could sustain
autophagy in VPS34-inactive cells, we fur-
ther confirmed that PI(5)P was involved
in glucose starvation- or resveratrol-
induced autophagy, where PI(3)P is
dispensable. Indeed, glucose starvation-
induced autophagy appeared to be depen-
dent on PI(5)P and not PI(3)P.
Our analysis reveals a hitherto unknown
functional interplay between PIKfyve and
PI5P4Ks in controlling PI(5)P levels in the
context of autophagy and will pave the way
for further studies of this exciting lipid in
physiological cellular processes, including
neurodegeneration and cancer. This may
have therapeutic potential, because PIKfyve
and PI5P4K enzymes are druggable targets
and our data indicate that suppression of
Figure 1. PI(5)P regulates autophagosome biogenesis. (A) Schematic representation of pathways for PI(5)P synthesis/turnover and enzymes involved in
these pathways. PI5P4K, type II phosphatidylinositol 5-phosphate 4-kinase; PIKfyve, type III phosphatidylinositol 5-phosphate 5-kinase; VPS34, class III
phosphatidylinositol 3-kinase; PIK3C2A, class II phosphatidylinositol 3-kinase; MTMR, myotubularin related 3-phosphatase. (B) PI(5)P (red) is found on
pre-phagophore structures, phagophores, and autophagosomes, and stabilizes membrane-bound WIPI2 on autophagic precursors. WIPI2 binding
recruits the ATG16L1-5-12 complex, which enables phagophore biogenesis and subsequent LC3 lipidation and autophagic substrate degradation. PI(5)P
metabolism on autophagosomes seems to be highly dependent on PIKfyve and PI5P4K activities. Importantly, although we found that PI(3)P (green)
was required for amino acid starvation-induced autophagy, PI(5)P synthesis was essential for autophagy activation by both amino acid and glucose
depletion. Thus, we have identiﬁed PI(5)P as a new master regulator of glucose starvation-induced autophagy through a PI(3)P-independent autophagy
pathway.
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PI5P4K activity increased the clearance of
autophagic substrates associated with neu-
rodegenerative disease. Autophagy induc-
tion via other signaling effectors has benefits
in a wide range of cell and animal models of
neurodegenerative diseases caused by aggre-
gate-prone intracytoplasmic proteins, like
Huntington’s and Parkinson’s disease.
Thus, PI5P4K inhibition may provide a
tractable therapeutic target for such condi-
tions. On the other hand, understanding
the enzymes that regulate autophagy via PI
(5)P may also enable inhibition of the path-
way in cancers. This may be relevant inmet-
astatic cancers where autophagy
upregulation induced by theWarburg effect
might contribute to tumor survival.
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